Oncology & Cancer

The behavior of therapeutic antibodies in immunotherapy

Since the late 1990s, immunotherapy has been the frontline treatment against lymphomas where synthetic antibodies are used to stop the proliferation of cancerous white blood cells. However, in the more than 20 years since ...

Oncology & Cancer

Gene discovery may explain female melanoma survival advantage

Centenary Institute scientists have discovered that genes on the X chromosome may be key to the improved survival rates of females with melanoma–as compared to their male counterparts. The findings could ultimately lead ...

Vaccination

COVID-19 vaccine candidate shows positive preclinical results

PDS Biotechnology, a clinical stage immunotherapy company, has announced positive results from preclinical testing conducted at the University of Kentucky College of Medicine of its COVID-19 vaccine candidate, PDS0203.

Oncology & Cancer

Internal differences: A new method for seeing into cells

Invading cells' private space—prying into their internal functions, decisions and communications—could be a powerful tool that may help researchers develop new immunotherapy treatment for cancer. As reported today in ...

Vaccination

New Russian virus vaccine one among many

With Russia's announcement Tuesday that it had become the first country to approve a vaccine against COVID-19, here is a look at the more than two dozen other candidates currently in development.

Diseases, Conditions, Syndromes

New insights into the immune system's role in severe COVID-19

By conducting advanced analyses of immune system activation in patients with severe COVID-19, researchers at Karolinska Institutet have managed to identify several cell types that play a key part in the immune response to ...

page 1 from 100